home

Home> Industry News >Trend >Main Body

Industry News

GSK Announces Positive Results From Phase III BLISS-SC Study of Benlysta(R) (Belimumab) Administered Subcutaneously In Patients With Systemic Lupus Erythematosus (SLE)

2015-11-12 14:23

Source：GSK,Belimumab,SLE

Read：1233 Favorite 0

Share

相关阅读

You may interest

Copyright©2020 药渡经纬信息科技（北京）有限公司电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |（京）-经营性-2015-0023（互联网药品信息服务资格证书）

: 药渡APP

: 微信二维码